Variable | Non-MTX | MTX | p |
---|---|---|---|
Patients, n (%) | 69 (74) | 24 (26) | — |
Age, yrs | 51.5 | 59 | 0.024* |
Female sex | 49.3% | 62.5% | 0.34 |
ADAb-positive | 39.1% | 16.7% | 0.049* |
High ADAb concentration | 21.7% | 16.7% | 0.77 |
Therapeutic drug level | 72.5% | 91.7% | 0.086 |
DAS28 | 3.2 | 4 | 0.02* |
VAS | 26 | 31 | 0.45 |
PASI | 3.5 | 3.5 | 0.99 |
BASDAI | 3.6 | 6 | 0.17 |
↵* Significant data. MTX: methotrexate; ADAb: antidrug antibodies; DAS28: 28-joint Disease Activity Score; VAS: visual analog scale; PASI: Psoriasis Area and Severity Index; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index.